Linas, France

Fatima Chorki

This inventor holds 2 USPTO granted patents. Top assignee: Centre National De La Recherche Scientifique. Active years: 2008-2010.


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2008-2010

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Fatima Chorki: Innovator in Malaria Treatment

Introduction

Fatima Chorki is a prominent inventor based in Linas, France. She has made significant contributions to the field of medicine, particularly in the development of treatments for malaria. Her innovative work has led to the creation of new artemisinin derivatives that hold promise in combating this deadly disease.

Latest Patents

Fatima Chorki holds 2 patents related to her research. Her latest patents include "Derivatives of artemisinin, and their uses in the treatment of malaria," which introduces a new artemisinin derivative of a specific general formula. Another patent, "Artemisinin derivatives, and uses thereof for treating malaria," also focuses on a new artemisinin derivative with potential therapeutic applications.

Career Highlights

Fatima Chorki is affiliated with the Centre National de la Recherche Scientifique, a leading research institution in France. Her work at this esteemed organization has allowed her to explore innovative solutions to pressing health issues, particularly malaria.

Collaborations

Throughout her career, Fatima has collaborated with notable colleagues, including Jean-Pierre Begue and Danièle Bonnet-Delpon. These partnerships have enriched her research and contributed to the advancement of her projects.

Conclusion

Fatima Chorki's contributions to malaria treatment through her innovative artemisinin derivatives highlight her role as a key inventor in the field. Her work continues to inspire advancements in medical research and offers hope for improved treatments against malaria.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…